Kalbe Farma, ID1000096605

Kalbe Neurobion Forte - Kalbe Farma targets everyday nerve health

05.07.2026 - 01:12:46 | ad-hoc-news.de

Kalbe Neurobion Forte delivers high-dose B vitamins for nerve health in a simple daily tablet, widely sold across Indonesia’s pharmacies. Anyone holding Kalbe Farma stock (IDX: KLBF, ISIN ID1000096605) should know this product.

Kalbe Farma, ID1000096605
Kalbe Farma, ID1000096605

By Daniel Foster, ad hoc news B2B & Pro Desk. Reviewed July 04, 2026, 7:12 PM ET. Details in the imprint.

Kalbe Neurobion Forte sits in a bright red-and-white box on a Jakarta pharmacy counter, a line of patients watching as the pharmacist flips each blister strip to check the lot code. The tablet is small, chalky, and slightly bitter, meant to be swallowed with water after meals.

High-dose B vitamins for nerves

Neurobion Forte is Kalbe Farma’s high-dose vitamin B complex formulation focused on peripheral nerve health, combining vitamin B1, B6, and B12 in one prescription-strength tablet for adults with neuropathy-related complaints.

The official Kalbe product page describes Neurobion Forte as indicated for neuritis and neuralgia, with each tablet containing thiamine 100 mg, pyridoxine 200 mg, and cyanocobalamin 200 mcg, taken one to three times daily according to a physician’s advice.

Positioned in Indonesia’s pharmacy channel

In Kalbe’s home market of Indonesia, Neurobion Forte is primarily dispensed through pharmacies and drugstores, often kept behind the counter and recommended by doctors for tingling sensations, numbness, or pain linked to nerve disorders.

Walking into a Kimia Farma outlet in central Jakarta, you see Neurobion packs stacked beside analgesics and diabetes medications, a reminder of how often nerve pain overlaps with chronic conditions such as diabetes.

Dig deeper

Kalbe Farma’s vitamin and prescription portfolio

For investors tracking Kalbe Farma stock, Neurobion Forte sits inside a broader vitamins and prescription drug portfolio that supports recurring revenue.

Formulation details and dosing

Kalbe’s formulation for Neurobion Forte focuses on three essential B vitamins: thiamine for carbohydrate metabolism and nerve impulse transmission, pyridoxine for neurotransmitter synthesis, and cyanocobalamin for myelin maintenance and red blood cell formation.

The high dosages distinguish Neurobion Forte from over-the-counter multivitamins, with pyridoxine at 200 mg per tablet exceeding typical daily dietary requirements and necessitating medical supervision to manage risks of excessive B6 exposure over long periods.

Clinical use and patient experience

Doctors in Indonesia often prescribe Neurobion Forte as an adjunct in peripheral neuropathy linked to diabetes, alcohol misuse, or other metabolic disorders, aiming to correct vitamin B deficiencies that aggravate nerve pain and paresthesia.

Patients describe a routine of taking the small white tablet after breakfast, hoping for reduced electric shock sensations in their feet or a less intense burning feeling at night, though symptom improvement can take weeks and varies widely between individuals.

Safety profile and cautions

According to Kalbe’s product information, Neurobion Forte is generally well tolerated when taken as directed, but prolonged high-dose vitamin B6 use may cause sensory neuropathy, so physicians typically limit treatment duration and monitor clinical response and side effects closely.

Pregnant or breastfeeding women, and patients with severe liver or kidney impairment, are advised to consult doctors before using Neurobion Forte, as vitamin metabolism and excretion can be altered in these populations.

Market positioning versus standard Neurobion

Kalbe also sells a standard Neurobion product with lower vitamin B doses aimed at mild deficiency or maintenance, while Neurobion Forte is positioned for more pronounced nerve symptoms under physician care.

In pharmacy displays, the two variants are often placed side by side, the Forte packs marked clearly to avoid confusion for patients and to align the higher-dose formulation with prescription-led sales rather than casual self-medication.

Brand recognition and advertising

Neurobion has become a familiar name in Indonesia, supported by Kalbe’s longstanding marketing campaigns that emphasize helping people manage everyday nerve discomfort so they can keep working and stay active.

Television and digital ads have historically portrayed office workers rubbing their neck or lower back, then showing a doctor recommending Neurobion as part of a broader therapy, reinforcing the message that nerve pain is treatable and deserves medical attention.

Role for US investors

For US investors, Neurobion Forte matters less as a product they can buy and more as a contributor to Kalbe’s domestic revenue, supporting a stable, recurring stream from Indonesia’s large and aging population.

Kalbe Farma stock (IDX: KLBF) trades in Indonesian rupiah on the Indonesia Stock Exchange, with no New York listing; however, the company’s vitamins and prescription brands, including Neurobion Forte, underpin its healthcare presence across Southeast Asia.

Key facts about Kalbe Neurobion Forte

  • Product: Kalbe Neurobion Forte
  • Manufacturer: PT Kalbe Farma Tbk
  • Category: B2B and Pro healthcare line
  • Launch: Marketed in Indonesia for several years as a high-dose vitamin B complex tablet for peripheral neuropathy
  • MSRP / Price: Typically priced in Indonesian rupiah per blister pack in local pharmacies; pricing varies by outlet and region
  • Availability: Widely available in Indonesian pharmacies and clinics; not formally marketed in the US
  • Target audience: Adult patients with peripheral neuropathy symptoms under physician care
  • Standout / USP: High-dose combination of B1, B6, and B12 in a single tablet aimed specifically at nerve health

Follow Kalbe Neurobion Forte

This article was AI-assisted and editorially reviewed. Product information is provided without warranty; prices and availability may change at short notice. Not investment advice and not a buy or sell recommendation. Securities trading carries risks up to total loss.

en | ID1000096605 | KALBE FARMA | boerse | 69691730 | bgmi